This announcement read almost exactly as I anticipated: further testing required. Not surprising considering the unique mode of action and potency of the drug. Reading past the usual spin, I still think it's a positive and, if anything, highlighted how cutting edge this technology is. Looking back, the previous announcement had really spelled out that the minutes were going to about recommendations moving the company forward into clinical trials. Be great to have more details from the minutes though. Definitely not a sell signal for me.
Ann: Update on meeting with US FDA, page-9
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $118.1M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 46.5¢ | $2.131K | 4.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1263 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 11173 | 5 |
View Market Depth
| Last trade - 12.38pm 04/12/2024 (20 minute delay) ? |
| RCE (ASX) Chart |
